Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Speci
Background: Researchers are testing version of a system known as a magnetic resonance imagining (MRI) scanner that uses strong magnetic fields, radio waves and the like to create images of the organs in the body. It uses lower energy levels than other MRI scanners. This may help scan people with metal devices in their
| Condition(s) | CAD |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Background: Researchers are testing version of a system known as a magnetic resonance imagining (MRI) scanner that uses strong magnetic fields, radio waves and the like to create images of the organs in the body. It uses lower energy levels than other MRI scanners. This may help scan people with metal devices in their body, or in invasive heart procedures using metal tools. Objective: To test a new MRI scanner and software changes to create better pictures. Eligibility: People with disease and healthy volunteers, ages 18 and older. Design: Participants will be screened with blood tests. Participants may have both the new MRI and a conventional MRI or only the new one. If 2 are done, they must be within 60 days. For both MRI versions, participants lie on a table that slides into a large tub |
| Who can participate | * INCLUSION CRITERIA: Inclusion Criteria for All Participants (Objectives 1, 2, 3, and 4) * Men and women age greater than or equal to 18 years * Able to provide informed consent in writing * Willingness to cooperate with all study procedures (including food restriction) and available for scheduled study events Inclusion Criteria for Healthy Volunteers (Objectives 1 and 2) -Currently healthy, self-reported Inclusion Criteria for Subjects with Heart Disease (Objective 3) * Subjects having known heart disease including but not limited to * Stable angina pectoris due to epicardial coronary artery obstruction * Past myocardial infarction * Heart failure with reduced ejection fraction * Valvular heart disease * Pulmonary artery hypertension * Congenital heart disease with or without prior repai |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI) |
| Locations | Bethesda, Maryland, United States |
| Start date | 2018-01-05 |
| NCT ID | NCT03331380 |
| Official listing | https://clinicaltrials.gov/study/NCT03331380 |